Company profile: Syner-G BioPharma
1.1 - Company Overview
Company description
- Provider of pharmaceutical development and CMC solutions; cGMP and quality/compliance services; regulatory strategy and submissions spanning CMC, nonclinical, and clinical; functional outsourcing partnerships with dedicated regulatory staff; medical writing for scientifically accurate, compliant documents; and CMC consulting focused on strategy, compliance, and process optimization in drug development.
Products and services
- Regulatory Strategy & Submissions: Delivers full-spectrum guidance through the regulatory landscape with strategies across CMC, nonclinical, and clinical areas to support submissions
- Quality & Compliance: Offers cGMP-focused services ranging from quality management to document oversight, supporting regulatory adherence throughout development
- Pharmaceutical Development (CMC): Supplies CMC-integrated systems for drug substance and drug product development, aligning Chemistry, Manufacturing, and Controls to ensure compliance and market readiness
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Syner-G BioPharma
Therapak
HQ: United States
Website
- Description: Provider of diagnostic and medical device kitting services for clinical trials and healthcare, including protocol management, kit development, global distribution, and configurable collection kits, supported by PASSPORT online systems. Offers clinical supply packaging for temperature-sensitive shipments, specialized specimen collection and transport products, including customizable test-specific kits and temperature-controlled shipping systems, and an online hazardous materials training course.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Therapak company profile →
Q1 Scientific
HQ: Ireland
Website
- Description: Provider of environmentally controlled stability storage services for the pharmaceutical, medical device and life sciences industries.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Q1 Scientific company profile →
Berkshire Sterile Manufacturing
HQ: United States
Website
- Description: Provider of small-scale sterile manufacturing services for clinical use, delivering the safest sterile drug products with the highest level of sterility assurance and quality through modern sterile manufacturing technologies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Berkshire Sterile Manufacturing company profile →
ProQinase
HQ: Germany
Website
- Description: Provider of contract research services, founded in 2001 as a subsidiary of the Tumor Biology Center Freiburg. Originated to support the center’s in-house anti-cancer drug development by marketing research tools, with roots in a cancer center that combined research and patient care.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ProQinase company profile →
Gallus BioPharma
HQ: United States
Website
- Description: Provider of contract manufacturing and development services for mammalian cell culture-derived biologics, supplying clinical and commercial bulk biologics to the biopharmaceutical industry in the United States and internationally, with capabilities in process and analytical development, process validation, cell banking, stability testing, QA/QC, regulatory support, and aseptic fill-finish (vial filling, inspection, labeling).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Gallus BioPharma company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Syner-G BioPharma
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Syner-G BioPharma
2.2 - Growth funds investing in similar companies to Syner-G BioPharma
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Syner-G BioPharma
4.2 - Public trading comparable groups for Syner-G BioPharma
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →